A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales
<p>Abstract</p> <p>Background</p> <p>Postnatal and antenatal anti-D prophylaxis have dramatically reduced maternal sensitisations and cases of rhesus disease in babies born to women with RhD negative blood group. Recent scientific advances mean that non-invasive prenata...
Main Authors: | Osipenko Leeza, Szczepura Ala, Freeman Karoline |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | BMC Pregnancy and Childbirth |
Online Access: | http://www.biomedcentral.com/1471-2393/11/5 |
Similar Items
-
Noninvasive fetal RHD genotyping from maternal plasma
by: Disha S Parchure, et al.
Published: (2016-01-01) -
Genotipagem RHD através da análise do plasma materno Fetal RHD genotyping by analysis of the maternal plasma
by: Isabela Nelly Machado
Published: (2005-02-01) -
Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review
by: Britta Runkel, et al.
Published: (2020-02-01) -
Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.
by: Eleonor Tiblad, et al.
Published: (2013-01-01) -
Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation
by: H Pilgrim, et al.
Published: (2009-02-01)